Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
KANT Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 25, 2025
Report Source: 2024 3rd Quarter Report
Kineta Inc. Stock Analysis KANT
United States Health Care Nano Cap Report: Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. The company is headquartered in Mercer Island, Washington and currently employs 4 full-time employees. The company went IPO on 2016-02-11. The firm has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance: immunosuppression, exhausted T cells and poor tumor immunogenicity. Its pipeline of immunotherapies includes KVA12123, which is a monoclonal antibody (mAb), immunotherapy targeting VISTA (V-domain Ig suppressor of T cell activation), and an anti-CD27 agonist mAb immunotherapy. The innate immune target VISTA is highly expressed in many types of cancer, including non-small cell lung cancer (NSCLC), colorectal cancer, ovarian cancer, renal cell carcinoma, and head and neck squamous cell carcinoma. The firm is also developing an anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. The nominated lead candidate is a fully human mAb that demonstrates nanomolar (nM) binding affinity to CD27 in humans.
Read More Kineta Inc (KANT) Chart
Key Statistics of Kineta Inc (KANT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.30Volume
360.00P/E Ratio (TTM)
-52 Week Range
Market Cap
3.93MAvg. Volume
23.22KDividend Yield
-Financial Metrics & Statements of Kineta Inc (KANT)
FAQ's for Kineta Inc (KANT)
- According to Musaffa’s Shariah screening methodology, Kineta Inc (KANT) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kineta Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kineta Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kineta Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kineta Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kineta Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.